Doctor-supervised weight loss with Ozempic, Mounjaro & Wegovy – now in Kerala & Coimbatore.


Indians face a unique challenge. Research shows that one-third of Indians with “normal” weight actually carry dangerous levels of hidden fat.
Indian doctor body fat
Same BMI. Completely different health risk.
This is called the “skinny-fat” phenotype. Indians store fat around internal organs (visceral fat) – not under the skin where it’s visible. This hidden fat causes diabetes, heart disease, and metabolic problems
High Risk
High Risk
If your waist is above these numbers, you likely have visceral fat – even if you look “normal.”
Medical weight loss means doctor-supervised treatment using proven medications, structured nutrition, and exercise guidance.
Result: You feel satisfied with less food. Cravings reduce. Weight loss becomes achievable.
Reduce hunger signals. Decrease food cravings.
Slow digestion. Feel full longer after meals.
Improve insulin function. Better blood sugar control.
Change how and where your body stores fat.
(Semaglutide)
GLP-1 receptor agonist, once-weekly injection
Higher-dose semaglutide, specifically for weight management
Note: Your doctor will recommend the appropriate medication based on your health profile, goals, and budget. Not everyone needs the highest dose or most expensive option.

Studies show that 45% of weight lost during GLP-1 treatment is muscle – not just fat.
Losing 15 kg? About 7 kg could be muscle.
This is dangerous because:



This is exactly what the SuperHuman Program provides.
Important: Our doctors screen for all contraindications before prescribing any medication.
Outcome: Personalized treatment plan if you qualify.

Dr. Sarath Chandran, MBBS, MD (DVL)
Dr. Sarath Chandran, MBBS, MD (DVL), is a leading dermatologist and the clinical lead for the SuperHuman Medical Weight Loss & Longevity Program at DermaVue Thiruvalla. He is widely trusted for his evidence-based approach to medical dermatology, metabolic health, and long-term patient care.
With over 4 years of dedicated clinical experience, Dr. Sarath combines his strong foundation in internal medicine and dermatology with modern metabolic science to manage obesity, belly fat, insulin resistance, and weight-related skin and hair conditions. As the supervising physician for the weight loss program, he oversees doctor-led protocols involving GLP-1–based therapies, medication optimization, and safe insulin de-escalation, working closely with dieticians and the clinical team to ensure patient safety and sustainable results.
Yes, when properly supervised. Our doctors screen for contraindications, start with low doses, and monitor throughout treatment. The health risks of untreated obesity – diabetes, heart disease, stroke – are typically greater than medication risks for appropriate candidates.
Ozempic has extensive safety data from clinical trials and millions of patients worldwide. Side effects are mostly gastrointestinal and manageable. However, it requires proper medical evaluation – this is why we do not prescribe without full assessment.
Yes – Type 2 diabetes is actually a primary indication. These medications improve both weight and blood sugar. Diabetic patients need monitoring for low blood sugar, especially if taking insulin or sulfonylureas.
DermaVue operates seven advanced dermatology clinics across Kerala and Tamil Nadu. Our physician-led team specializes in medical dermatology, cosmetic procedures, hair restoration, and now comprehensive metabolic health through the SuperHuman Program.
Medical Disclaimer: This information is educational and does not constitute medical advice. Individual results vary. All treatments require medical consultation. GLP-1 medications are prescription-only and require physician supervision.
Copyright © 2026 dermavue. All Rights Reserved.
DermaVue Clinic Support
Our team usually replies within minutes
Any questions about your skin or hair or treatments ?
WhatsApp Us
Start chat with our care team now
WhatsApp us